Blerta Kertusha
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
- HIV/AIDS Research and Interventions 1
- Virology 2
- Poxvirus research and outbreaks 1
- Co-authors
- Miriam Lichtner (13 shared papers)Cosmo Del Borgo (12 shared papers)Anna Carraro (12 shared papers)Claudio Maria Mastroianni (9 shared papers)Raffaella Marocco (12 shared papers)Paola Zuccalà (5 shared papers)Maria Antonella Zingaropoli (5 shared papers)Maria Rosa Ciardi (5 shared papers)
- Journals
- Viruses (3 papers)International Journal of Molecular Sciences (2 papers)Frontiers in Immunology (2 papers)PLoS ONE (2 papers)Cardiovascular Diabetology (1 paper)
- Partner nations
- ItalyIrelandSwitzerland
In The Last Decade
Blerta Kertusha
18 papers receiving 637 citations
Blerta Kertusha's Hit Papers
Peers
Comparison fields: 5 of 91
- Infectious Diseases 356
- Applied Microbiology and Biotechnology 17
- Neurology 117
- Critical Care and Intensive Care Medicine 17
- Obstetrics and Gynecology 16
Countries citing papers authored by Blerta Kertusha
This map shows the geographic impact of Blerta Kertusha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blerta Kertusha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blerta Kertusha more than expected).
Fields of papers citing papers by Blerta Kertusha
This network shows the impact of papers produced by Blerta Kertusha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blerta Kertusha. The network helps show where Blerta Kertusha may publish in the future.
Co-authors
The 25 scholars most cited alongside Blerta Kertusha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 289 |
| 2 | 2020 | 91 | |
| 3 | 2020 | 85 | |
| 4 | 2021 | 71 | |
| 5 | 2020 | 25 | |
| 6 | 2018 | 18 | |
| 7 | 2022 | 14 | |
| 8 | 2018 | 11 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2023 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2023 | 0 | |
| 20 | 2024 | 0 |
About Blerta Kertusha
Blerta Kertusha is a scholar working on Infectious Diseases, Virology, Clinical Biochemistry, Emergency Medicine and Neurology, having authored 20 papers that have together received 646 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Bacterial Identification and Susceptibility Testing (2 papers), Long-Term Effects of COVID-19 (2 papers), HIV-related health complications and treatments (2 papers), Poxvirus research and outbreaks (1 paper), Animal Virus Infections Studies (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Infectious Diseases (356 citations), Applied Microbiology and Biotechnology (17 citations), Neurology (117 citations), Critical Care and Intensive Care Medicine (17 citations) and Obstetrics and Gynecology (16 citations). Blerta Kertusha has collaborated with scholars based in Italy, Ireland and Switzerland. Frequent co-authors include Miriam Lichtner, Cosmo Del Borgo, Anna Carraro, Claudio Maria Mastroianni, Raffaella Marocco, Paola Zuccalà, Maria Antonella Zingaropoli, Maria Rosa Ciardi, Patrizia Pasculli and Parni Nijhawan. Their work appears in journals such as Viruses, International Journal of Molecular Sciences, Frontiers in Immunology, PLoS ONE and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.